This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk03: Ladies and gentlemen, good day and welcome to the Yatsen Third Quarter 2023 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Irene Liu, Vice President, Head of Strategic Investments and Capital Markets. Please go ahead.
spk01: Thank you, Operator. Please note the discussion today will contain four local statements relating to the company's future performance. and are intended to qualify for the safe harbor from liability established by the US private security litigation reform act. Such statements are not guarantees of future performance and are subject to certain risks and uncertainties, assumptions, and other factors. Some of these risks are beyond the company's control and could cause actual results to differ materially from those mentioned in today's press release and this discussion. A general discussion of the risk factor could affect Yashin's business and financial results is included in certain filings of the company with the Securities and Exchange Commission. The company does not undertake any obligation to update this forelooking information except as required by law. During today's call, management will also discuss certain non-GAAP financial measures for comparison purposes only. Please see the earnings release issued earlier today for a definition of non-GAAP financial measures and a reconciliation of GAAP to non-GAAP financial results. Joining us today on the call from Yasin's senior management team are Mr. Jingfeng Huang, our founder, chairman, and CEO, and Mr. Zhonghao Yang, our CFO and director. Management will begin with prepared remarks, and the call will conclude with a Q&A session. As a reminder, this conference is new recorded. In addition, a webcast replay of this conference call will also be available on Yasin's investor relations website at ir.yasinglobal.com. I'll now turn the call over to Mr. Sunfeng Huang. Go ahead, sir.
spk02: Thank you, Irene. and thank you everyone for participating in Yat-San's third quarter 2023 earnings conference call today. In the third quarter of 2023, China's building industry remained in the mild recovery phase that began as the country emerged from the pandemic earlier this year. According to the National Bureau of Statistics of China, total retail sales of consumer goods grew by 4.2% year-over-year, and the total beauty retail sales increased by 2.6% year-over-year, both representing a deceleration in year-over-year growth rate from the second quarter. Online beauty sales showed a similar pattern in the third quarter. For both color cosmetics and skincare, combined total sales on Timor and Douyin recorded a slower growth rate than in the second quarter of 2023. Amid uncertainties in consumer demand, Yasan remained committed to its strategic transformation plan. We continuously strive to build strong brand equity based on superior product performance and consumer satisfaction. For the third quarter of 2023, We recorded total net revenue of RMB 718.1 million, in line with our previous guidance. Net revenue for our skincare brand declined by 4.1% year over year, mainly attributable to our strategy decision to phase out the AB's Choice brand. Our clinical and premium skincare brands, including Galanique, Dr. Wu, and Yves Long, delivered another solid performance, recording 7.4% year-over-year growth in combined with net revenues, and a further increasing debt contribution to total net revenues as compared with the prior year period. Net revenues from color cosmetics brands decreased by 21.5% year-over-year, primarily due to the decline in perfect diary sales, as a result of the timing of new product launches near the end of the third quarter and the closure of underperforming offline stores. The number of Perfect Diaries offline stores totaled 123 as of the end of the third quarter, compared with 198 a year ago. Net revenue from Little Undine and Pin Bear continued to grow as both brands raise their brand awareness among targeted consumers. YesSense growth margin improved to 71.4% in the third quarter from 68.9% in the prior year period. Due to the rising contribution from higher growth margin skincare brands and ongoing cost optimization across our brand portfolio, Net lose and the non-GAAP net lose margin expanded to 27.6% and 80.1%, respectively, as we increased investment in the Perfect Diary brand upgrade and the preparation for the Double 11 Shopping Festival. Turning now to our brands and products. During the third quarter of 2023, We repositioned the Perfect Diary brand, carrying out a series of campaigns with the refreshed visual identities and new product launches. The brand's new hero product, BioLip Essence Lipstick, leverages our exclusive BioLip technology, which creates a bionic sebum film upon application to protect the lips' fragile skin barriers. BioList's strong efficacy in lip line reduction was validated by the prestigious Ruijin Hospital and the SGS testing agency. Our two other color cosmetics brands, Little Ondine and PinBear, both formed co-branding partnerships with popular IPs that deeply resonated with young consumers. For our skincare brand, we continued to engage deeply in brand building, further cultivating each brand's distinctive audience. Galanique marked its 45th anniversary with a gala celebration that hosted an array of celebrities, media, and scholars in Paris. The brand also officially announced its scientific research cooperation with Hospital St. Louis. a well-known dermatology hospital in Paris, and established the Galenic Dermatology Research Foundation. In addition, Dr. Wu celebrated his 20th anniversary. His reputation as a high-quality clinical brand and a pioneer in the use of a magnetic acid continued to strengthen as the brand was honored as Asia's leading mandelic-based skincare brand by U.N. Monitor, the world's top independent provider of multi-research and industry analysis. Furthermore, Yif Long introduced renowned singer and actor Xiao Zhan as his brand ambassador to increase brand awareness and establish a broader customer base. Moving on to R&D, R&D expenses as a percentage of revenues were 3.4%. In September, Yasen and Galanick Brand attended the IFSCC conference in Barcelona, Spain, and presented a scientific paper on the brand's patent no-algae peptide. At the conference, Galanick also announced that it has entered into strategy cooperation with the global peptide leader, Lubizol, to jointly research new ingredients, collaborate on anti-aging product research, and expand YASEN's open lab research and development boundaries. Before handing the call over to Dong Hao, I would like to provide an update on our share repurchase program. As announced earlier today, our board of directors has approved and authorized a change to the size and term of our share repurchase program, increasing the aggregate value of shares that may be repurchased under the share repurchase program from US$150 million to US$200 million, and extending the effective term of the share repurchase program through November 19, 2025. This further demonstrates our confidence in Yasheng's process. To summarize, China's beauty market is still in the process of a modest recovery this year. Looking forward, we will continue to adapt flexibly and are confident in our resources and ability to advance our strategic transformation plan. With that, I will now turn the call over to our CFO, Donghao Yang, to discuss our financial performance. Thank you, everyone.
spk04: Thank you, David, and hello, everyone. Before I get started, I would like to clarify that all financial numbers presented today are in RMB amounts, and all percentage changes refer to year-over-year changes, unless otherwise noted. Total net revenues for the third quarter of 2023 decreased by 16.3%, to $718.1 million from $857.9 million for the prior year period. The decrease was primarily attributable to a 21.5% year-over-year decrease in net revenues from color cosmetics brands combined with a 4.1% year-over-year decrease in net revenues from skincare brands. Growth profits for the third quarter of 2023 decreased by 13.3% to $512.8 million from $591.3 million for the prior year period. Growth margin in the third quarter of 2023 increased to 71.4% from 68.9% for the prior year period. The increase was driven by first increasing sales of higher gross margin products from skincare brands. And secondly, more disciplined pricing and discount policies. And thirdly, cost optimization across all of our brand portfolios. Total operating expenses for the third quarter of 2023 decreased by 13.1% to $744.3 million from $857 million for the prior year period. As a percentage of total net revenues, total operating expenses for the third quarter of 2023 were 103.6% as compared with 99.9% for the prior year period. Supplement expenses for the third quarter of 2023 were $56 million as compared with 63.8 million for the prior year period. As a percentage of total net revenues, fulfillment expenses for the third quarter of 2023 increased to 7.8% from 7.4% for the prior year period. The increase was primarily attributable to the deleveraging effect of lower net revenues in the third quarter of 2023. Selling and marketing expenses for the third quarter of 2023 were $511.7 million as compared with $564.8 million for the prior year period. As a percentage of total net revenues, selling and marketing expenses for the third quarter of 2023 increased to 71.3% from 65.8% for the prior year period. The increase was primarily attributable to increased investments in the Perfect Diary brand upgrades and preparations for the Double Eleven Shopping Festival. General and administrative expenses for the third quarter of 2023 were $151.8 million as compared with $194.5 million for the prior year period. As a percentage of total net revenues, general and administrative expenses for the third quarter of 2023 decreased to 21.1% from 22.7% for the prior year period. The decrease was primarily attributable to a reduction in compensation corresponding to a decrease in general and administrative headcount. Research and development expenses for the third quarter of 2023 were $24.7 million as compared with $33.9 million for the prior year period. As a percentage of total net revenues, research and development expenses for the third quarter of 2023 decreased to 3.4% from 3.9% for the prior year period. The decrease was primarily attributable to our efforts to maintain research and development expenses at a reasonable level relative to total net revenues. Loss from operations for the third quarter of 2023 decreased by 12.9% to $231.5 million from $265.7 million for the prior year period. Operating loss margin was 32.2%. as compared with 31% for the prior year period. Non-GAAP loss from operations for the third quarter of 2023 increased by 1.2% to $164.6 million from $162.6 million for the prior year period. Non-GAAP operating loss margin was 22.9% as compared with 19%. for the prior year period. Net loss for the third quarter of 2023 decreased by 6.1% to $197.9 million from $210.7 million for the prior year period. Net loss margin was 27.6% as compared with 24.6% for the prior year period. Net loss attributable to yes and ordinary shareholders for diluted ADS for the third quarter of 2023 was 0.36 as compared with 0.37 for the prior year period. Non-GAAP net loss for the third quarter of 2023 increased by 3% to $130.2 million from $126.5 million for the prior year period. net loss margin was 18.1% as compared with 14.7% for the prior year period. Non-GAAP net loss attributable to Yassin's ordinary shareholders for diluted ADS for the third quarter of 2023 was 0.24 as compared with 0.22 for the prior year period. As of September 30, 2023, we had cash, restricted cash, and short-term investments of 2.24 billion RMB as compared with 2.63 billion RMB as of December 31, 2022. Net cash use in operating activities for the third quarter of 2023 was 163.4 million RMB. compared with net cash generated from operating activities of $21.8 million for the prior year period. Looking at our business outlook for the fourth quarter of 2023, we expect our total net revenues to be between $1.01 billion and $1.06 billion, representing a 0% to 5% increase year over year. These forecasts reflect our current and preliminary views on the market and operational conditions, which are subject to change. With that, I would now like to open the call to Q&A.
spk03: Yes, thank you. We will now begin the question and answer session. To ask a question, you may press star, then 1 on your touch-tone phone. If you are using a speakerphone, please pick up your handset before pressing the keys. To withdraw your question, please press star then 2. For the benefit of all participants on today's call, if you wish to ask your question to management in Chinese, please immediately repeat your question in English. At this time, we will pause momentarily to assemble the roster. And the first question comes from Man Kuei Huang with CICC.
spk00: Well, thanks for taking my question. This is Maggie Huang from CICC. I have two questions. The first one is regarding the new products of Perfect Diary. We've seen the launch of BioLip Essence Lipstick and also foundations in Q3. So is there any feedback we've got from the customers, and how should we expect on their performance in next year? This is for the first question. And my second question is about our guidance. We've guided a positive revenue growth for Q4, which is an encouraging signal. So behind this guidance, could management give us more color on your expectation for both skin care and color cosmetic sectors in Q4? And what are the key drivers for us to achieve that goal? That's my question. Thank you.
spk01: So, yeah, thank you for the question. Let me take the first one. For Perfect Diary's new lipstick launch, which is the Bio Essence lipstick, after it launched in end of September, we have received very positive feedback from our users as they enjoyed a very strong efficacy from the lipstick. Basically, our philosophy is to have a very perfect makeup look combined with skin-level efficacy benefits from the lipstick. So that's number one. And then secondly, the user profile also started to shift after our brand upgrade and also the new launch. Historically, our consumers are mostly Gen Zs and also young consumers from the lower tier cities. But then after we launched this new product and the brand upgrade, given that our price point started to increase and with new look and benefits, we start to see more high-value consumers coming to buy our lipstick, including, for example, the sophisticated young moms and also the upper middle class. And also, since the launch, we have seen very positive ranking performance on both Tmall and Douyin. So the launch of this lipstick was only at the end of September, so it hasn't really contributed to much of the Q3 performance, but in Q4 and W11, we continue to see this product to gain market share.
spk04: Yeah, and your second question, I think Irene has already covered part of the answer for your question. We launched our new product for Perfect Diary towards the end of, mid to end of September, Q3, and the sales contribution from those new products was started to show on our P&Ls starting in Q4. So that's one reason. One other reason is Q4 has traditionally been a strong season for our skincare products. And if you look at our skincare products, the three main skincare brands have been growing really fast in the past many quarters. and we are expecting strong growth from those skincare brands. All in all, with the slowdown of the decline, sales decline of Perfect Diarrhea brand and strong growth from those other skincare brands, that's why we are expecting a strong quarter in Q4, and therefore we give the guidance of 0 to 5% year-over-year growth. As you know, in the past almost two years, the sales of the company have been declining, and hopefully that decline has bottomed out, and we do expect our sales to start to gain traction in the foreseeable future.
spk00: I got it. That's very helpful. Thank you very much, and I have no more questions.
spk03: Thank you. And once again, please press star then 1 if you would like to ask a question. And once more as a reminder, star then 1 will allow you to ask a question. All right, this concludes the question and answer session. I would like to turn the call to Irene Liu for any closing comments.
spk01: Thank you once again for joining us today. If you have any other further questions, please feel free to contact us at Yasen directly or at TSM Financial Communications. Our contact information for IR in both China and the U.S. can be found in today's press release. Have a great day. Thank you.
spk03: Thank you. The conference is now concluded. Thank you for attending today's presentation.
Disclaimer